EUVIMEDEUVIMED entdecken
Open Access

Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau

Kai Chen, Yosuke M Morizawa, Tal Nuriel, Osama Al-Dalahmah, Zhongcong Xie, Guang Yang

Neuron · 2025-08 · 113 (15) · 2438-2454.e6

DOI: 10.1016/j.neuron.2025.04.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2025-08. Verfasst von Kai Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY 10032, USA. Hauptthemen laut MEDLINE: eIF-2 Kinase, Astrocytes, tau Proteins, Amyloid beta-Peptides. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysfunction of the glymphatic system, a brain-wide waste clearance network, is strongly linked to Alzheimer's disease (AD) and the accumulation of β-amyloid (Aβ) and tau proteins. Here, we identify an astrocytic signaling pathway that can be targeted to preserve glymphatic function and mitigate neurotoxic protein buildup. Analysis of astrocytes from both human AD brains and two transgenic mouse models (5XFAD and PS19) reveals robust activation of the protein kinase RNA-like endoplasmic reticulum (ER) kinase (PERK)-α subunit of eukaryotic initiation factor 2 (eIF2α) branch of the unfolded protein response. Chronic PERK activation suppresses astrocytic protein synthesis and, through casein kinase 2 (CK2)-dependent mechanisms, disrupts the perivascular localization of aquaporin-4 (AQP4), a water channel essential for glymphatic flow. Importantly, astrocyte-specific PERK deletion or pharmacological inhibition restores AQP4 localization, enhances glymphatic clearance, reduces Aβ and tau pathology, and improves cognitive performance in mice. These findings highlight the critical role of the astrocytic PERK-CK2-AQP4 axis in glymphatic dysfunction and AD pathogenesis, positioning this pathway as a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

eIF-2 KinaseAstrocytestau ProteinsAmyloid beta-PeptidesGlymphatic SystemAlzheimer DiseaseAnimalsMice, TransgenicHumansMiceAquaporin 4MaleDisease Models, Animal

Stichwörter der Autor:innen

ADAQP4CK2PERKastrocyteglymphatic functionprotein synthesisunfolded protein response

Substanzen

eIF-2 Kinasetau ProteinsAmyloid beta-PeptidesAquaporin 4

Autor:innen und Institutionen

  • Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Pathology and Cell Biology, Columbia University Irving Medical Ce…
  • Geriatric Anesthesia Research Unit, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. Electronic address: zhongcong.Xie@uth…
  • Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: gy2268@cumc.columbia.edu.

Förderung

  • NIA NIH HHS
  • National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Chen, K., Morizawa, Y. M., Nuriel, T., Al-Dalahmah, O., Xie, Z., & Yang, G. (2025). Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau. Neuron, 113(15), 2438-2454.e6. https://doi.org/10.1016/j.neuron.2025.04.027

Vancouver

Chen K, Morizawa YM, Nuriel T, Al-Dalahmah O, Xie Z, Yang G. Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau. Neuron. 2025;113(15):2438-2454.e6. doi:10.1016/j.neuron.2025.04.027

BibTeX
@article{Chen2025,
  author = {Chen, Kai and Morizawa, Yosuke M and Nuriel, Tal and Al-Dalahmah, Osama and Xie, Zhongcong and Yang, Guang},
  title = {Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau},
  journal = {Neuron},
  year = {2025},
  volume = {113},
  number = {15},
  pages = {2438--2454.e6},
  doi = {10.1016/j.neuron.2025.04.027}
}
Kostenlos starten →